Psychopharmacology

, Volume 184, Issue 3–4, pp 367–381

Nicotine as a typical drug of abuse in experimental animals and humans

Review

Abstract

Rationale and background

Tobacco use through cigarette smoking is the leading preventable cause of death in the developed world. Nicotine, a psychoactive component of tobacco, appears to play a major role in tobacco dependence, but reinforcing effects of nicotine often are difficult to demonstrate directly in controlled laboratory studies with animal or human subjects.

Objective

To review the major findings obtained with various procedures developed to study dependence-related behavioral effects of nicotine in experimental animals and humans, i.e., drug self-administration, conditioned place preference, subjective reports of nicotine effects and nicotine discrimination, withdrawal signs, and ratings of drug withdrawal.

Results

Nicotine can function as an effective reinforcer of drug-seeking and drug-taking behavior both in experimental animals and humans under appropriate conditions. Interruption of chronic nicotine exposure produces withdrawal symptoms that may contribute to relapse. Difficulties encountered in demonstrating reinforcing effects of nicotine under some conditions, relative to other drugs of abuse, may be due to weaker primary reinforcing effects of nicotine or to a more critical contribution of environmental stimuli to the maintenance of drug-seeking and drug-taking behavior with nicotine than with other drugs of abuse. Further experiments are also needed to delineate the role other chemical substances inhaled along with nicotine in tobacco smoke play in sustaining smoking behavior.

Conclusion

Nicotine acts as a typical drug of abuse in experimental animals and humans.

References

  1. Adriani W, Spijker S, Deroche-Gamonet V, Laviola G, Le Moal M, Smit AB, Piazza PV (2003) Evidence for enhanced neurobehavioral vulnerability to nicotine during periadolescence in rats. J Neurosci 23:4712–4716PubMedGoogle Scholar
  2. Ahmed SH, Koob GF (1998) Transition from moderate to excessive drug intake: change in hedonic set point. Science 282:298–300CrossRefPubMedGoogle Scholar
  3. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders. American Psychiatric Association, Washington, DCGoogle Scholar
  4. Ando K, Miyata H, Hironaka N, Tsuda T, Yanagita T (1993) The discriminative effects of nicotine and their central sites in rats. Yakubutsu Seishin Kodo 13:129–136PubMedGoogle Scholar
  5. Andreoli M, Tessari M, Pilla M, Valerio E, Hagan JJ, Heidbreder CA (2003) Selective antagonism at dopamine D3 receptors prevents nicotine-triggered relapse to nicotine-seeking behavior. Neuropsychopharmacology 28:1272–1280CrossRefPubMedGoogle Scholar
  6. Anthenelli RM, Despres JP (2004) Effects of Rimonabant in the reduction of major cardiovascular risk factors. Results from the STRATUS-US trial (smoking cessation in smokers motivated to quit). American College of Cardiology 53rd Annual Scientific Session, New Orleans, LA, USAGoogle Scholar
  7. Arroyo M, Markou A, Robbins TW, Everitt BJ (1999) Acquisition, maintenance and reinstatement of intravenous cocaine self-administration under a second-order schedule of reinforcement in rats: effects of conditioned cues and continuous access to cocaine. Psychopharmacology (Berl) 140:331–344CrossRefGoogle Scholar
  8. Ator NA, Griffiths RR (1983) Nicotine self-administration in baboons. Pharmacol Biochem Behav 19:993–1003CrossRefPubMedGoogle Scholar
  9. Balster RL (1992) Preclinical methods for the development of pharmacotherapies of cocaine abuse. In: Harris LS (ed) Problems of drug dependence. National Institute on Drug Abuse, Rockville, pp 160–164Google Scholar
  10. Bardo MT, Bevins RA (2000) Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology (Berl) 153:31–43CrossRefGoogle Scholar
  11. Belluzzi JD, Lee AG, Oliff HS, Leslie FM (2004a) Age-dependent effects of nicotine on locomotor activity and conditioned place preference in rats. Psychopharmacology (Berl) 174:389–395Google Scholar
  12. Belluzzi JD, Wang R, Leslie FM (2004b) Acetaldehyde enhances acquisition of nicotine self-administration in adolescent rats. Neuropsychopharmacology (in press). DOI 10.1038/sj.npp.1300586Google Scholar
  13. Berlin I, Anthenelli RM (2001) Monoamine oxidases and tobacco smoking. Int J Neuropsychopharmacol 4:33–42CrossRefPubMedGoogle Scholar
  14. Brody AL, Mandelkern MA, London ED, Childress AR, Lee GS, Bota RG, Ho ML, Saxena S, Baxter LR Jr, Madsen D, Jarvik ME (2002) Brain metabolic changes during cigarette craving. Arch Gen Psychiatry 59:1162–1172CrossRefPubMedGoogle Scholar
  15. Brody AL, Mandelkern MA, Lee G, Smith E, Sadeghi M, Saxena S, Jarvik ME, London ED (2004) Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study. Psychiatry Res 130:269–281PubMedGoogle Scholar
  16. Brower VG, Fu Y, Matta SG, Sharp BM (2002) Rat strain differences in nicotine self-administration using an unlimited access paradigm. Brain Res 930:12–20CrossRefPubMedGoogle Scholar
  17. Bruijnzeel AW, Markou A (2003) Characterization of the effects of bupropion on the reinforcing properties of nicotine and food in rats. Synapse 50:20–28CrossRefPubMedGoogle Scholar
  18. Buczek Y, Le AD, Stewart J, Shaham Y (1999) Stress reinstates nicotine seeking but not sucrose solution seeking in rats. Psychopharmacology (Berl) 144:183–188CrossRefGoogle Scholar
  19. Butschky MF, Bailey D, Henningfield JE, Pickworth WB (1995) Smoking without nicotine delivery decreases withdrawal in 12-hour abstinent smokers. Pharmacol Biochem Behav 50:91–96CrossRefPubMedGoogle Scholar
  20. Caggiula AR, Donny EC, White AR, Chaudhri N, Booth S, Gharib MA, Hoffman A, Perkins KA, Sved AF (2001) Cue dependency of nicotine self-administration and smoking. Pharmacol Biochem Behav 70:515–530CrossRefPubMedGoogle Scholar
  21. Caggiula AR, Donny EC, Chaudhri N, Perkins KA, Evans-Martin FF, Sved AF (2002) Importance of nonpharmacological factors in nicotine self-administration. Physiol Behav 77:683–687CrossRefPubMedGoogle Scholar
  22. Chance WT, Murfin D, Krynock GM, Rosecrans JA (1977) A description of the nicotine stimulus and tests of its generalization to amphetamine. Psychopharmacology (Berl) 55:19–26CrossRefGoogle Scholar
  23. Chaudhri N, Caggiula AR, Donny EC, Palmatier mI, Liu X, Sved AF (2005) Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement. Psychopharmacology (Berl) (in press)Google Scholar
  24. Chiamulera C, Borgo C, Falchetto S, Valerio E, Tessari M (1996) Nicotine reinstatement of nicotine self-administration after long-term extinction. Psychopharmacology (Berl) 127:102–107Google Scholar
  25. Cohen C, Perrault G, Voltz C, Steinberg R, Soubrie P (2002) SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats. Behav Pharmacol 13:451–463PubMedGoogle Scholar
  26. Cohen C, Perrault G, Griebel G, Soubrie P (2005) Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB(1)) receptor antagonist, Rimonabant (SR141716). Neuropsychopharmacology 30:145–155CrossRefPubMedGoogle Scholar
  27. Colpaert FC (1999) Drug discrimination in neurobiology. Pharmacol Biochem Behav 64:337–345CrossRefPubMedGoogle Scholar
  28. Corrigall WA, Coen KM (1989) Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology (Berl) 99:473–478CrossRefGoogle Scholar
  29. Corrigall WA, Coen KM (1994) Dopamine mechanisms play at best a small role in the nicotine discriminative stimulus. Pharmacol Biochem Behav 48:817–820CrossRefPubMedGoogle Scholar
  30. Cryan JF, Gasparini F, van Heeke G, Markou A (2003a) Non-nicotinic neuropharmacological strategies for nicotine dependence: beyond bupropion. Drug Discov Today 8:1025–1034CrossRefPubMedGoogle Scholar
  31. Cryan JF, Bruijnzeel AW, Skjei KL, Markou A (2003b) Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat. Psychopharmacology (Berl) 168:347–358CrossRefGoogle Scholar
  32. Dar R, Frenk H (2002) Nicotine self-administration in animals: a reevaluation. Addict Res Theory 10:545–579CrossRefGoogle Scholar
  33. Dar R, Frenk H (2004) Do smokers self-administer pure nicotine? A review of the evidence. Psychopharmacology (Berl) 173:18–26CrossRefGoogle Scholar
  34. de Wit H, Stewart J (1981) Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology (Berl) 75:134–143CrossRefGoogle Scholar
  35. Deneau GA, Inoki R (1967) Nicotine self-administration in monkeys. Ann N Y Acad Sci 142:277–279Google Scholar
  36. DeNoble VJ, Mele PC (2005) Intravenous nicotine self-administration in rats: effects of mecamylamine, hexamethonium and naloxone. Psychopharmacology (Berl) (in press). DOI 10.1007/s00213-005-6054-zGoogle Scholar
  37. Deroche-Gamonet V, Belin D, Piazza PV (2004) Evidence for addiction-like behavior in the rat. Science 305:1014–1017CrossRefPubMedGoogle Scholar
  38. Desai RI, Barber DJ, Terry P (2003) Dopaminergic and cholinergic involvement in the discriminative stimulus effects of nicotine and cocaine in rats. Psychopharmacology (Berl) 167:335–343Google Scholar
  39. Donny EC, Caggiula AR, Knopf S, Brown C (1995) Nicotine self-administration in rats. Psychopharmacology (Berl) 122:390–394CrossRefGoogle Scholar
  40. Donny EC, Caggiula AR, Mielke MM, Booth S, Gharib MA, Hoffman A, Maldovan V, Shupenko C, McCallum SE (1999) Nicotine self-administration in rats on a progressive ratio schedule of reinforcement. Psychopharmacology (Berl) 147:135–142CrossRefGoogle Scholar
  41. Donny EC, Chaudhri N, Caggiula AR, Evans-Martin FF, Booth S, Gharib MA, Clements LA, Sved AF (2003) Operant responding for a visual reinforcer in rats is enhanced by noncontingent nicotine: implications for nicotine self-administration and reinforcement. Psychopharmacology (Berl) 169:68–76CrossRefGoogle Scholar
  42. Due DL, Huettel SA, Hall WG, Rubin DC (2002) Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: evidence from functional magnetic resonance imaging. Am J Psychiatry 159:954–960CrossRefPubMedGoogle Scholar
  43. Epping-Jordan MP, Watkins SS, Koob GF, Markou A (1998) Dramatic decreases in brain reward function during nicotine withdrawal. Nature 393:76–79CrossRefPubMedGoogle Scholar
  44. Epstein DH, Preston KL (2003) The reinstatement model and relapse prevention: a clinical perspective. Psychopharmacology (Berl) 168:31–41CrossRefGoogle Scholar
  45. Erb S, Shaham Y, Stewart J (1996) Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period. Psychopharmacology (Berl) 128:408–412CrossRefGoogle Scholar
  46. Ettenberg A, Geist TD (1991) Animal model for investigating the anxiogenic effects of self-administered cocaine. Psychopharmacology (Berl) 103:455–461CrossRefGoogle Scholar
  47. Everitt BJ, Robbins TW (2000) Second-order schedules of drug reinforcement in rats and monkeys: measurement of reinforcing efficacy and drug-seeking behaviour. Psychopharmacology (Berl) 153:17–30CrossRefGoogle Scholar
  48. Fiore MC (2000) US public health service clinical practice guideline: treating tobacco use and dependence. Respir Care 45:1200–1262PubMedGoogle Scholar
  49. Fiore MC, Bailey WC, Cohen SJ, Dorfman SF, Goldstein MG, Gritz ER (2000) Treating tobacco use and dependence. Clinical practice guideline. Public Health Service. US Department of Health and Human Service, Washington, DCGoogle Scholar
  50. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, Alexoff D, Shea C, Schlyer D, Wolf AP, Warner D, Zezulkova I, Cilento R (1996a) Inhibition of monoamine oxidase B in the brains of smokers. Nature 379:733–736CrossRefPubMedGoogle Scholar
  51. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, Shea C, Alexoff D, MacGregor RR, Schlyer DJ, Zezulkova I, Wolf AP (1996b) Brain monoamine oxidase a inhibition in cigarette smokers. Proc Natl Acad Sci U S A 93:14065–14069CrossRefPubMedGoogle Scholar
  52. Garrett BE, Griffiths RR (2001) Intravenous nicotine and caffeine: subjective and physiological effects in cocaine abusers. J Pharmacol Exp Ther 296:486–494PubMedGoogle Scholar
  53. George TP, O'Malley SS (2004) Current pharmacological treatments for nicotine dependence. Trends Pharmacol Sci 25:42–48CrossRefPubMedGoogle Scholar
  54. Glassman AH, Helzer JE, Covey LS, Cottler LB, Stetner F, Tipp JE, Johnson J (1990) Smoking, smoking cessation, and major depression. JAMA 264:1546–1549CrossRefPubMedGoogle Scholar
  55. Glassman AH, Covey LS, Stetner F, Rivelli S (2001) Smoking cessation and the course of major depression: a follow-up study. Lancet 357:1929–1932CrossRefPubMedGoogle Scholar
  56. Goldberg SR (1975) Stimuli associated with drug injections as events that control behavior. Pharmacol Rev 27:325–340PubMedGoogle Scholar
  57. Goldberg SR, Henningfield JE (1988) Reinforcing effects of nicotine in humans and experimental animals responding under intermittent schedules of i.v. drug injection. Pharmacol Biochem Behav 30:227–234CrossRefPubMedGoogle Scholar
  58. Goldberg SR, Spealman RD (1982) Maintenance and suppression of behavior by intravenous nicotine injections in squirrel monkeys. Fed Proc 41:216–220PubMedGoogle Scholar
  59. Goldberg SR, Spealman RD (1983) Suppression of behavior by intravenous injections of nicotine or by electric shocks in squirrel monkeys: effects of chlordiazepoxide and mecamylamine. J Pharmacol Exp Ther 224:334–340PubMedGoogle Scholar
  60. Goldberg SR, Kelleher RT, Morse WH (1975) Second-order schedules of drug injection. Fed Proc 34:1771–1776PubMedGoogle Scholar
  61. Goldberg SR, Spealman RD, Kelleher RT (1979) Enhancement of drug-seeking behavior by environmental stimuli associated with cocaine or morphine injections. Neuropharmacology 18:1015–1017CrossRefPubMedGoogle Scholar
  62. Goldberg SR, Kelleher RT, Goldberg DM (1981a) Fixed-ratio responding under second-order schedules of food presentation or cocaine injection. J Pharmacol Exp Ther 218:271–281PubMedGoogle Scholar
  63. Goldberg SR, Spealman RD, Goldberg DM (1981b) Persistent behavior at high rates maintained by intravenous self-administration of nicotine. Science 214:573–575PubMedGoogle Scholar
  64. Goldberg SR, Spealman RD, Risner ME, Henningfield JE (1983) Control of behavior by intravenous nicotine injections in laboratory animals. Pharmacol Biochem Behav 19:1011–1020CrossRefPubMedGoogle Scholar
  65. Harvey DM, Yasar S, Heishman SJ, Panlilio LV, Henningfield JE, Goldberg SR (2004) Nicotine serves as an effective reinforcer of intravenous drug-taking behavior in human cigarette smokers. Psychopharmacology (Berl) 175:134–142Google Scholar
  66. Helton DR, Modlin DL, Tizzano JP, Rasmussen K (1993) Nicotine withdrawal: a behavioral assessment using schedule controlled responding, locomotor activity, and sensorimotor reactivity. Psychopharmacology (Berl) 113:205–210CrossRefGoogle Scholar
  67. Henningfield JE, Goldberg SR (1983a) Control of behavior by intravenous nicotine injections in human subjects. Pharmacol Biochem Behav 19:1021–1026CrossRefPubMedGoogle Scholar
  68. Henningfield JE, Goldberg SR (1983b) Nicotine as a reinforcer in human subjects and laboratory animals. Pharmacol Biochem Behav 19:989–992CrossRefPubMedGoogle Scholar
  69. Henningfield JE, Miyasato K, Jasinski DR (1985) Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine. J Pharmacol Exp Ther 234:1–12PubMedGoogle Scholar
  70. Hill RT (1970) Facilitation of conditioned reinforcement as a mechanism of psychomotor stimulation. In: Costa E, Garattini S (eds) Amphetamines and related compounds. Raven, New York, pp 781–795Google Scholar
  71. Hodos W (1961) Progressive ratio as a measure of reward strength. Science 134:943–944PubMedGoogle Scholar
  72. Huestis MA, Gorelick DA, Heishman SJ, Preston KL, Nelson RA, Moolchan ET, Frank RA (2001) Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. Arch Gen Psychiatry 58:322–328CrossRefPubMedGoogle Scholar
  73. Hughes JR (1989) Environmental determinants of the reinforcing effects of nicotine in humans. J Subst Abuse 1:319–329Google Scholar
  74. Hughes JR, Hatsukami D (1986) Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 43:289–294PubMedGoogle Scholar
  75. Hughes JR, Hatsukami DK, Pickens RW, Krahn D, Malin S, Luknic A (1984) Effect of nicotine on the tobacco withdrawal syndrome. Psychopharmacology (Berl) 83:82–87CrossRefGoogle Scholar
  76. Hughes JR, Hatsukami DK, Skoog KP (1986) Physical dependence on nicotine in gum. A placebo substitution trial. JAMA 255:3277–3279CrossRefPubMedGoogle Scholar
  77. Hughes JR, Gust SW, Skoog K, Keenan RM, Fenwick JW (1991) Symptoms of tobacco withdrawal. A replication and extension. Arch Gen Psychiatry 48:52–59PubMedGoogle Scholar
  78. Hughes JR, Higgins ST, Bickel WK (1994) Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities. Addiction 89:1461–1470CrossRefPubMedGoogle Scholar
  79. Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC, Khayrallah MA, Schroeder DR, Glover PN, Sullivan CR, Croghan IT, Sullivan PM (1997) A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 337:1195–1202CrossRefPubMedGoogle Scholar
  80. Isola R, Vogelsberg V, Wemlinger TA, Neff NH, Hadjiconstantinou M (1999) Nicotine abstinence in the mouse. Brain Res 850:189–196CrossRefPubMedGoogle Scholar
  81. Jones HE, Garrett BE, Griffiths RR (1999) Subjective and physiological effects of intravenous nicotine and cocaine in cigarette smoking cocaine abusers. J Pharmacol Exp Ther 288:188–197PubMedGoogle Scholar
  82. Jorenby D (2002) Clinical efficacy of bupropion in the management of smoking cessation. Drugs 62(Suppl 2):25–35CrossRefPubMedGoogle Scholar
  83. Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, Smith SS, Muramoto ML, Daughton DM, Doan K, Fiore MC, Baker TB (1999) A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 340:685–691CrossRefPubMedGoogle Scholar
  84. Kalman D (2002) The subjective effects of nicotine: methodological issues, a review of experimental studies, and recommendations for future research. Nicotine Tob Res 4:25–70CrossRefPubMedGoogle Scholar
  85. Katz JL, Goldberg SR (1988) Preclinical assessment of abuse liability of drugs. Agents Actions 23:18–26CrossRefPubMedGoogle Scholar
  86. Katz JL, Higgins ST (2003) The validity of the reinstatement model of craving and relapse to drug use. Psychopharmacology (Berl) 168:21–30CrossRefGoogle Scholar
  87. Kumar R, Reavill C, Stolerman IP (1987) Nicotine cue in rats: effects of central administration of ganglion-blocking drugs. Br J Pharmacol 90:239–246PubMedGoogle Scholar
  88. Lamb RJ, Preston KL, Schindler CW, Meisch RA, Davis F, Katz JL, Henningfield JE, Goldberg SR (1991) The reinforcing and subjective effects of morphine in post-addicts: a dose–response study. J Pharmacol Exp Ther 259:1165–1173PubMedGoogle Scholar
  89. Laviolette SR, Van Der Kooy D (2003) Blockade of mesolimbic dopamine transmission dramatically increases sensitivity to the rewarding effects of nicotine in the ventral tegmental area. Mol Psychiatry 8:50–59CrossRefPubMedGoogle Scholar
  90. Le Foll B, Goldberg SR (2004) Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences. Neuroreport 15:2139–2143CrossRefPubMedGoogle Scholar
  91. Le Foll B, Goldberg SR (2005a) Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence. J Pharmacol Exp Ther 312:875–883CrossRefPubMedGoogle Scholar
  92. Le Foll B, Goldberg SR (2005b) Control of the reinforcing effects of nicotine by associated environmental stimuli in animals and humans. Trends Pharmacol Sci 26:287–293CrossRefPubMedGoogle Scholar
  93. Le Foll B, Goldberg SR (2005c) Nicotine induces conditioned place preferences over a large range of doses in rats. Psychopharmacology (Berl) 178:481–492CrossRefGoogle Scholar
  94. Le Foll B, Schwartz J-C, Sokoloff P (2000) Dopamine D3 receptor agents as potential new medications for drug addiction. Eur Psychiatry 15:140–146CrossRefPubMedGoogle Scholar
  95. Le Foll B, Schwartz J-C, Sokoloff P (2003a) Disruption of nicotine conditioning by dopamine D3 receptor ligands. Mol Psychiatry 8:225–230CrossRefPubMedGoogle Scholar
  96. Le Foll B, Diaz J, Sokoloff P (2003b) Increased dopamine D3 receptor expression accompanying behavioural sensitization to nicotine in rats. Synapse 47:176–183CrossRefPubMedGoogle Scholar
  97. Le Foll B, Goldberg SR, Sokoloff P (2005a) Dopamine D3 receptor and drug dependence: effect on reward or beyond? Neuropharmacology 49:525–541CrossRefPubMedGoogle Scholar
  98. Le Foll B, Melihan-Cheinin P, Rostoker G, Lagrue G, for the working group of AFSSAPS (2005b) Smoking cessation guidelines: evidence-based recommendations of the French Health Products Safety Agency. Eur Psychiatry (in press)Google Scholar
  99. Le Foll B, Sokoloff P, Stark H, Goldberg SR (2005c) Dopamine D3 ligands block nicotine-induced conditioned place preferences through a mechanism that does not involve discriminative-stimulus or antidepressant-like effects. Neuropsychopharmacology 30:720–730PubMedGoogle Scholar
  100. LeSage MG, Keyler DE, Shoeman D, Raphael D, Collins G, Pentel PR (2002) Continuous nicotine infusion reduces nicotine self-administration in rats with 23-h/day access to nicotine. Pharmacol Biochem Behav 72:279–289CrossRefPubMedGoogle Scholar
  101. LeSage MG, Keyler DE, Collins G, Pentel PR (2003) Effects of continuous nicotine infusion on nicotine self-administration in rats: relationship between continuously infused and self-administered nicotine doses and serum concentrations. Psychopharmacology (Berl) 170:278–286CrossRefGoogle Scholar
  102. Lesage MG, Burroughs D, Dufek M, Keyler DE, Pentel PR (2004) Reinstatement of nicotine self-administration in rats by presentation of nicotine-paired stimuli, but not nicotine priming. Pharmacol Biochem Behav 79:507–513CrossRefPubMedGoogle Scholar
  103. Lindblom N, de Villiers SH, Kalayanov G, Gordon S, Johansson AM, Svensson TH (2002) Active immunization against nicotine prevents reinstatement of nicotine-seeking behavior in rats. Respiration 69:254–260CrossRefPubMedGoogle Scholar
  104. Malin DH, Lake JR, Newlin-Maultsby P, Roberts LK, Lanier JG, Carter VA, Cunningham JS, Wilson OB (1992) Rodent model of nicotine abstinence syndrome. Pharmacol Biochem Behav 43:779–784CrossRefPubMedGoogle Scholar
  105. Manzardo AM, Stein L, Belluzzi JD (2002) Rats prefer cocaine over nicotine in a two-lever self-administration choice test. Brain Res 924:10–19CrossRefPubMedGoogle Scholar
  106. Markou A, Weiss F, Gold LH, Caine B, Schulteis G, Koob GF (1993) Animal models of drug craving. Psychopharmacology (Berl) 112:163–182CrossRefGoogle Scholar
  107. Martellotta MC, Kuzmin A, Zvartau E, Cossu G, Gessa GL, Fratta W (1995) Isradipine inhibits nicotine intravenous self-administration in drug-naive mice. Pharmacol Biochem Behav 52:271–274CrossRefPubMedGoogle Scholar
  108. Meil WM, See RE (1996) Conditioned cue recovery of responding following prolonged withdrawal from self-administered cocaine in rats: an animal model of relapse. Behav Pharmacol 7:754–763PubMedGoogle Scholar
  109. Miyata H, Ando K, Yanagita T (1999) Medial prefrontal cortex is involved in the discriminative stimulus effects of nicotine in rats. Psychopharmacology (Berl) 145:234–236CrossRefGoogle Scholar
  110. Miyata H, Ando K, Yanagita T (2002) Brain regions mediating the discriminative stimulus effects of nicotine in rats. Ann N Y Acad Sci 965:354–363PubMedCrossRefGoogle Scholar
  111. O'Brien CP (2003) Research advances in the understanding and treatment of addiction. Am J Addict 12(Suppl 2):S36–S47PubMedCrossRefGoogle Scholar
  112. Olausson P, Jentsch JD, Taylor JR (2003) Repeated nicotine exposure enhances reward-related learning in the rat. Neuropsychopharmacology 28:1264–1271CrossRefPubMedGoogle Scholar
  113. Olausson P, Jentsch JD, Taylor JR (2004) Nicotine enhances responding with conditioned reinforcement. Psychopharmacology (Berl) 171:173–178CrossRefGoogle Scholar
  114. Overstreet DH (1995) Differential effects of nicotine in inbred and selectively bred rodents. Behav Genet 25:179–185CrossRefPubMedGoogle Scholar
  115. Overstreet DH, Pucilowski O, Rezvani AH, Janowsky DS (1995) Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression. Psychopharmacology (Berl) 121:27–37CrossRefGoogle Scholar
  116. Panlilio LV, Yasar S, Nemeth-Coslett R, Katz JL, Henningfield JE, Solinas M, Heishman SJ, Schindler CW, Goldberg SR (2005) Human cocaine-seeking behavior and its control by drug-associated stimuli in the laboratory. Neuropsychopharmacology 30:433–443CrossRefPubMedGoogle Scholar
  117. Paterson NE, Markou A (2003) Increased motivation for self-administered cocaine after escalated cocaine intake. Neuroreport 14:2229–2232CrossRefPubMedGoogle Scholar
  118. Paterson NE, Markou A (2004) Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats. Psychopharmacology (Berl) 173:64–72CrossRefGoogle Scholar
  119. Paterson NE, Semenova S, Gasparini F, Markou A (2003) The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice. Psychopharmacology (Berl) 167:257–264Google Scholar
  120. Paterson NE, Froestl W, Markou A (2004) The GABA(B) receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat. Psychopharmacology (Berl) 172:179–186CrossRefGoogle Scholar
  121. Perkins KA (2004) Response to Dar and Frenk (2004), “Do smokers self-administer pure nicotine? A review of the evidence”. Psychopharmacology (Berl) 175:256–258; author reply 259–61Google Scholar
  122. Perkins KA, Grobe JE, Weiss D, Fonte C, Caggiula A (1996) Nicotine preference in smokers as a function of smoking abstinence. Pharmacol Biochem Behav 55:257–263CrossRefPubMedGoogle Scholar
  123. Perkins KA, Sanders M, D'Amico D, Wilson A (1997) Nicotine discrimination and self-administration in humans as a function of smoking status. Psychopharmacology (Berl) 131:361–370CrossRefGoogle Scholar
  124. Perkins KA, Sanders M, Fonte C, Wilson AS, White W, Stiller R, McNamara D (1999) Effects of central and peripheral nicotinic blockade on human nicotine discrimination. Psychopharmacology (Berl) 142:158–164CrossRefGoogle Scholar
  125. Perkins KA, Fonte C, Meeker J, White W, Wilson A (2001) The discriminative stimulus and reinforcing effects of nicotine in humans following nicotine pretreatment. Behav Pharmacol 12:35–44PubMedGoogle Scholar
  126. Picciotto MR, Brunzell DH, Caldarone BJ (2002) Effect of nicotine and nicotinic receptors on anxiety and depression. Neuroreport 13:1097–1106CrossRefPubMedGoogle Scholar
  127. Pomerleau CS, Pomerleau OF, Majchrzak MJ (1987) Mecamylamine pretreatment increases subsequent nicotine self-administration as indicated by changes in plasma nicotine level. Psychopharmacology (Berl) 91:391–393CrossRefGoogle Scholar
  128. Pratt JA, Stolerman IP, Garcha HS, Giardini V, Feyerabend C (1983) Discriminative stimulus properties of nicotine: further evidence for mediation at a cholinergic receptor. Psychopharmacology (Berl) 81:54–60CrossRefGoogle Scholar
  129. Rasmussen T, Swedberg MD (1998) Reinforcing effects of nicotinic compounds: intravenous self-administration in drug-naive mice. Pharmacol Biochem Behav 60:567–573CrossRefPubMedGoogle Scholar
  130. Rauhut AS, Neugebauer N, Dwoskin LP, Bardo MT (2003) Effect of bupropion on nicotine self-administration in rats. Psychopharmacology (Berl) 169:1–9CrossRefGoogle Scholar
  131. Reavill C, Stolerman IP, Kumar R, Garcha HS (1986) Chlorisondamine blocks acquisition of the conditioned taste aversion produced by (-)-nicotine. Neuropharmacology 25:1067–1069CrossRefPubMedGoogle Scholar
  132. Risner ME, Goldberg SR (1983) A comparison of nicotine and cocaine self-administration in the dog: fixed-ratio and progressive-ratio schedules of intravenous drug infusion. J Pharmacol Exp Ther 224:319–326PubMedGoogle Scholar
  133. Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 18:247–291CrossRefPubMedGoogle Scholar
  134. Robinson TE, Berridge KC (2001) Incentive-sensitization and addiction. Addiction 96:103–114CrossRefPubMedGoogle Scholar
  135. Robinson JH, Pritchard WS (1992) The role of nicotine in tobacco use. Psychopharmacology (Berl) 108:397–407CrossRefGoogle Scholar
  136. Robinson ML, Houtsmuller EJ, Moolchan ET, Pickworth WB (2000) Placebo cigarettes in smoking research. Exp Clin Psychopharmacol 8:326–332CrossRefPubMedGoogle Scholar
  137. Robinson SE, James JR, Lapp LN, Vann RE, Gross DF, Philibin SD, Rosecrans JA (2005) Evidence of cellular nicotinic receptor desensitization in rats exhibiting nicotine-induced acute tolerance. Psychopharmacology (Berl):1–8Google Scholar
  138. Rose JE, Corrigall WA (1997) Nicotine self-administration in animals and humans: similarities and differences. Psychopharmacology (Berl) 130:28–40CrossRefGoogle Scholar
  139. Rose JE, Sampson A, Levin ED, Henningfield JE (1989) Mecamylamine increases nicotine preference and attenuates nicotine discrimination. Pharmacol Biochem Behav 32:933–938CrossRefPubMedGoogle Scholar
  140. Rose JE, Behm FM, Westman EC, Levin ED, Stein RM, Ripka GV (1994) Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone. Clin Pharmacol Ther 56:86–99PubMedCrossRefGoogle Scholar
  141. Rose JE, Behm FM, Westman EC, Johnson M (2000) Dissociating nicotine and nonnicotine components of cigarette smoking. Pharmacol Biochem Behav 67:71–81CrossRefPubMedGoogle Scholar
  142. Rose JE, Behm FM, Westman EC (2001) Acute effects of nicotine and mecamylamine on tobacco withdrawal symptoms, cigarette reward and ad lib smoking. Pharmacol Biochem Behav 68:187–197CrossRefPubMedGoogle Scholar
  143. Rose JE, Behm FM, Westman EC, Bates JE, Salley A (2003a) Pharmacologic and sensorimotor components of satiation in cigarette smoking. Pharmacol Biochem Behav 76:243–250CrossRefPubMedGoogle Scholar
  144. Rose JE, Behm FM, Westman EC, Bates JE (2003b) Mecamylamine acutely increases human intravenous nicotine self-administration. Pharmacol Biochem Behav 76:307–313CrossRefPubMedGoogle Scholar
  145. Rosecrans JA (1979) Nicotine as a discriminative stimulus to behavior: its characterization and relevance to smoking behavior. NIDA Res Monogr:58–69Google Scholar
  146. Rosecrans JA, Meltzer LT (1981) Central sites and mechanisms of action of nicotine. Neurosci Biobehav Rev 5:497–501CrossRefPubMedGoogle Scholar
  147. Salin-Pascual RJ, Drucker-Colin R (1998) A novel effect of nicotine on mood and sleep in major depression. Neuroreport 9:57–60PubMedGoogle Scholar
  148. Salin-Pascual RJ, Rosas M, Jimenez-Genchi A, Rivera-Meza BL, Delgado-Parra V (1996) Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression. J Clin Psychiatry 57:387–389PubMedGoogle Scholar
  149. Samaha AN, Robinson TE (2005) Why does the rapid delivery of drugs to the brain promote addiction? Trends Pharmacol Sci 26:82–87CrossRefPubMedGoogle Scholar
  150. Sands SB, Brooks PR, Chambers LK, Coe JW, Liu Y, Rollema H, Rovetti CC, Schaeffer E, Schulz DW, Tingley FD, Mansbach RS (2005) A new therapy for smoking cessation: varenicline, a selective nicotinic receptor partial agonist SRNT's. 11th Annual Meeting and 7th Annual European Conference, PragueGoogle Scholar
  151. Sannerud CA, Prada J, Goldberg DM, Goldberg SR (1994) The effects of sertraline on nicotine self-administration and food-maintained responding in squirrel monkeys. Eur J Pharmacol 271:461–469CrossRefPubMedGoogle Scholar
  152. Schindler CW, Panlilio LV, Goldberg SR (2002) Second-order schedules of drug self-administration in animals. Psychopharmacology (Berl) 163:327–344CrossRefGoogle Scholar
  153. Schuster CR, Woods JH (1968) The conditioned reinforcing effects of stimuli associated with morphine reinforcement. Int J Addict 3:223–230Google Scholar
  154. Self DW, Nestler EJ (1988) Relapse to drug-seeking: neural and molecular mechanisms. Drug Alcohol Depend 51:49–60CrossRefGoogle Scholar
  155. Shaham Y, Rajabi H, Stewart J (1996) Relapse to heroin-seeking in rats under opioid maintenance: the effects of stress, heroin priming, and withdrawal. J Neurosci 16:1957–1963PubMedGoogle Scholar
  156. Shaham Y, Adamson LK, Grocki S, Corrigall WA (1997) Reinstatement and spontaneous recovery of nicotine seeking in rats. Psychopharmacology (Berl) 130:396–403CrossRefGoogle Scholar
  157. Shaham Y, Shalev U, Lu L, De Wit H, Stewart J (2002) The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl) 168:3–20CrossRefGoogle Scholar
  158. Shalev U, Grimm JW, Shaham Y (2002) Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev 54:1–42CrossRefPubMedGoogle Scholar
  159. Shiffman S, Shumaker SA, Abrams DB, Cohen S, Garvey A, Grunberg NE, Swan GE (1986) Models of smoking relapse. Health Psychol 5(Suppl):13–27CrossRefPubMedGoogle Scholar
  160. Shiffman S, Johnston JA, Khayrallah M, Elash CA, Gwaltney CJ, Paty JA, Gnys M, Evoniuk G, DeVeaugh-Geiss J (2000a) The effect of bupropion on nicotine craving and withdrawal. Psychopharmacology (Berl) 148:33–40CrossRefGoogle Scholar
  161. Shiffman S, Khayrallah M, Nowak R (2000b) Efficacy of the nicotine patch for relief of craving and withdrawal 7–10 weeks after cessation. Nicotine Tob Res 2:371–378PubMedGoogle Scholar
  162. Shiffman S, Shadel WG, Niaura R, Khayrallah MA, Jorenby DE, Ryan CF, Ferguson CL (2003) Efficacy of acute administration of nicotine gum in relief of cue-provoked cigarette craving. Psychopharmacology (Berl) 166:343–350Google Scholar
  163. Shoaib M, Stolerman IP (1995) Conditioned taste aversions in rats after intracerebral administration of nicotine. Behav Pharmacol 6:375–385PubMedGoogle Scholar
  164. Shoaib M, Stolerman IP, Kumar RC (1994) Nicotine-induced place preferences following prior nicotine exposure in rats. Psychopharmacology (Berl) 113:445–452CrossRefGoogle Scholar
  165. Shoaib M, Schindler CW, Goldberg SR (1997) Nicotine self-administration in rats: strain and nicotine pre-exposure effects on acquisition. Psychopharmacology (Berl) 129:35–43CrossRefGoogle Scholar
  166. Shoaib M, Gommans J, Morley A, Stolerman IP, Grailhe R, Changeux JP (2002) The role of nicotinic receptor beta-2 subunits in nicotine discrimination and conditioned taste aversion. Neuropharmacology 42:530–539CrossRefPubMedGoogle Scholar
  167. Shoaib M, Sidhpura N, Shafait S (2003) Investigating the actions of bupropion on dependence-related effects of nicotine in rats. Psychopharmacology (Berl) 165:405–412Google Scholar
  168. Silagy C, Mant D, Fowler G, Lancaster T (2000) Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev:CD000146Google Scholar
  169. Slifer BL, Balster RL (1985) Intravenous self-administration of nicotine: with and without schedule-induction. Pharmacol Biochem Behav 22:61–69CrossRefPubMedGoogle Scholar
  170. Sokoloff P, Diaz J, Le Foll B, Guillin O, Leriche L, Bezard E, Gross C (2005) The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders. Curr Drug Target CNS Neurol Disord (in press)Google Scholar
  171. Soria R, Stapleton JM, Gilson SF, Sampson-Cone A, Henningfield JE, London ED (1996) Subjective and cardiovascular effects of intravenous nicotine in smokers and non-smokers. Psychopharmacology (Berl) 128:221–226CrossRefGoogle Scholar
  172. Spealman RD (1983) Maintenance of behavior by postponement of scheduled injections of nicotine in squirrel monkeys. J Pharmacol Exp Ther 227:154–159PubMedGoogle Scholar
  173. Spealman RD, Goldberg SR (1978) Drug self-administration by laboratory animals: control by schedules of reinforcement. Annu Rev Pharmacol Toxicol 18:313–339CrossRefPubMedGoogle Scholar
  174. Spealman RD, Goldberg SR (1982) Maintenance of schedule-controlled behavior by intravenous injections of nicotine in squirrel monkeys. J Pharmacol Exp Ther 223:402–408PubMedGoogle Scholar
  175. Spealman RD, Goldberg SR, Gardner ML (1981) Behavioral effects of nicotine: schedule-controlled responding by squirrel monkeys. J Pharmacol Exp Ther 216:484–491PubMedGoogle Scholar
  176. Stewart J (1983) Conditioned and unconditioned drug effects in relapse to opiate and stimulant drug-administration. Prog Neuropsychopharmacol Biol Psychiatry 7:591–597CrossRefPubMedGoogle Scholar
  177. Stolerman IP (1988) Characterization of central nicotinic receptors by studies on the nicotine cue and conditioned taste aversion in rats. Pharmacol Biochem Behav 30:235–242CrossRefPubMedGoogle Scholar
  178. Stolerman IP (1989) Discriminative stimulus effects of nicotine in rats trained under different schedules of reinforcement. Psychopharmacology (Berl) 97:131–138CrossRefGoogle Scholar
  179. Stolerman IP (1999) Inter-species consistency in the behavioural pharmacology of nicotine dependence. Behav Pharmacol 10:559–580PubMedGoogle Scholar
  180. Stolerman IP, Shoaib M (1991) The neurobiology of tobacco addiction. Trends Pharmacol Sci 12:467–473CrossRefPubMedGoogle Scholar
  181. Stolerman IP, Garcha HS, Pratt JA, Kumar R (1984) Role of training dose in discrimination of nicotine and related compounds by rats. Psychopharmacology (Berl) 84:413–419CrossRefGoogle Scholar
  182. Stolerman IP, Chandler CJ, Garcha HS, Newton JM (1997) Selective antagonism of behavioural effects of nicotine by dihydro-beta-erythroidine in rats. Psychopharmacology (Berl) 129:390–397CrossRefGoogle Scholar
  183. Stolerman IP, Naylor C, Elmer GI, Goldberg SR (1999) Discrimination and self-administration of nicotine by inbred strains of mice. Psychopharmacology (Berl) 141:297–306CrossRefGoogle Scholar
  184. Suzuki T, Ise Y, Tsuda M, Maeda J, Misawa M (1996) Mecamylamine-precipitated nicotine-withdrawal aversion in rats. Eur J Pharmacol 314:281–284CrossRefPubMedGoogle Scholar
  185. Takada K, Hagen TJ, Cook JM, Goldberg SR, Katz JL (1988) Discriminative stimulus effects of intravenous nicotine in squirrel monkeys. Pharmacol Biochem Behav 30:243–247CrossRefPubMedGoogle Scholar
  186. Tashkin D, Kanner R, Bailey W, Buist S, Anderson P, Nides M, Gonzales D, Dozier G, Patel MK, Jamerson B (2001) Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. Lancet 357:1571–1575CrossRefPubMedGoogle Scholar
  187. Thorsteinsson HS, Gillin JC, Patten CA, Golshan S, Sutton LD, Drummond S, Clark CP, Kelsoe J, Rapaport M (2001) The effects of transdermal nicotine therapy for smoking cessation on depressive symptoms in patients with major depression. Neuropsychopharmacology 24:350–358CrossRefPubMedGoogle Scholar
  188. Tiffany ST, Cox LS, Elash CA (2000) Effects of transdermal nicotine patches on abstinence-induced and cue-elicited craving in cigarette smokers. J Consult Clin Psychol 68:233–240CrossRefPubMedGoogle Scholar
  189. Tizabi Y, Overstreet DH, Rezvani AH, Louis VA, Clark E Jr., Janowsky DS, Kling MA (1999) Antidepressant effects of nicotine in an animal model of depression. Psychopharmacology (Berl) 142:193–199CrossRefGoogle Scholar
  190. Tizabi Y, Rezvani AH, Russell LT, Tyler KY, Overstreet DH (2000) Depressive characteristics of FSL rats: involvement of central nicotinic receptors. Pharmacol Biochem Behav 66:73–77CrossRefPubMedGoogle Scholar
  191. Valentine JD, Hokanson JS, Matta SG, Sharp BM (1997) Self-administration in rats allowed unlimited access to nicotine. Psychopharmacology (Berl) 133:300–304CrossRefGoogle Scholar
  192. Vanderschuren LJ, Everitt BJ (2004) Drug seeking becomes compulsive after prolonged cocaine self-administration. Science 305:1017–1019CrossRefPubMedGoogle Scholar
  193. Vastola BJ, Douglas LA, Varlinskaya EI, Spear LP (2002) Nicotine-induced conditioned place preference in adolescent and adult rats. Physiol Behav 77:107–114CrossRefPubMedGoogle Scholar
  194. Villegier AS, Blanc G, Glowinski J, Tassin JP (2003) Transient behavioral sensitization to nicotine becomes long-lasting with monoamine oxidases inhibitors. Pharmacol Biochem Behav 76:267–274CrossRefPubMedGoogle Scholar
  195. Wakasa Y, Takada K, Yanagita T (1995) Reinforcing effect as a function of infusion speed in intravenous self-administration of nicotine in rhesus monkeys. Nihon Shinkei Seishin Yakurigaku Zasshi 15:53–59PubMedGoogle Scholar
  196. Waters AJ, Shiffman S, Sayette MA, Paty JA, Gwaltney CJ, Balabanis MH (2004) Cue-provoked craving and nicotine replacement therapy in smoking cessation. J Consult Clin Psychol 72:1136–1143CrossRefPubMedGoogle Scholar
  197. Watkins SS, Stinus L, Koob GF, Markou A (2000) Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects. J Pharmacol Exp Ther 292:1053–1064PubMedGoogle Scholar
  198. West RJ, Russell MA (1985) Effects of withdrawal from long-term nicotine gum use. Psychol Med 15:891–893PubMedCrossRefGoogle Scholar
  199. West RJ, Jarvis MJ, Russell MA, Carruthers ME, Feyerabend C (1984a) Effect of nicotine replacement on the cigarette withdrawal syndrome. Br J Addict 79:215–219PubMedGoogle Scholar
  200. West RJ, Russell MA, Jarvis MJ, Feyerabend C (1984b) Does switching to an ultra-low nicotine cigarette induce nicotine withdrawal effects? Psychopharmacology (Berl) 84:120–123CrossRefGoogle Scholar
  201. Wiley JL, Lavecchia KL, Martin BR, Damaj MI (2002) Nicotine-like discriminative stimulus effects of bupropion in rats. Exp Clin Psychopharmacol 10:129–135CrossRefPubMedGoogle Scholar
  202. Young R, Glennon RA (2002) Nicotine and bupropion share a similar discriminative stimulus effect. Eur J Pharmacol 443:113–118CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  1. 1.Preclinical Pharmacology Section, Behavioral Neuroscience Research Branch, National Institute on Drug Abuse, National Institutes of HealthDepartment of Health and Human ServicesBaltimoreUSA

Personalised recommendations